HER2 Assessment on Core Biopsies Using Monoclonal Antibody CB11 Accurately Determines HER2 Status In Breast Carcinoma

C. A. Purdie, L. Jordan, J. McCullough, S. Edwards, J. Cunningham, A. Grant, N. Pratt, A. Thompson

    Research output: Contribution to journalBook/Film/Article review

    Original languageEnglish
    Article number97P
    Pages (from-to)ii38-ii38
    Number of pages1
    JournalAnnals of Oncology
    Volume20
    Issue numberS2
    DOIs
    Publication statusPublished - May 2009

    Cite this

    Purdie, C. A., Jordan, L., McCullough, J., Edwards, S., Cunningham, J., Grant, A., Pratt, N., & Thompson, A. (2009). HER2 Assessment on Core Biopsies Using Monoclonal Antibody CB11 Accurately Determines HER2 Status In Breast Carcinoma. Annals of Oncology, 20(S2), ii38-ii38. [97P]. https://doi.org/10.1093/annonc/mdp102